RHO and pulmonary fibrosis: Hence, future investigations on Rho signaling pathway inhibitors may lead to an effective therapeutic option to prevent fibrosis and contracture in wounds, as well as to treat diseases that are characterized by excessive fibrosis, such as idiopathic pulmonary fibrosis (IPF).